IMPACT OF LEVOSIMENDAN ON RENAL FUNCTION IN COMPLEX TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE
Background. Levosimendan infusion can be used in the treatment of patients with acute decompensated heart failure (ADHF) with a reduction in cardiac output and signs of severe congestion/pulmonary edema.Aim. To study impact of levosimendan on renal function in patients with ADHF with reduced systoli...
Saved in:
Main Authors: | M. V. Lediakhova (Author), S. N. Nasonova (Author), I. V. Zhirov (Author), M. V. Andreevskaya (Author), R. M. Bogieva (Author), T. M. Uskach (Author), M. A. Saidova (Author), V. P. Masenko (Author), S. N. Tereshchenko (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2018-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SGLT-2 inhibitors in the management of acute decompensated heart failure
by: Anastasia E. Poskakalova, et al.
Published: (2024) -
Hyperuricemia and acute decompensation of heart failure: is there a causative link? A review
by: Laura H. Sarieva, et al.
Published: (2024) -
Safety of dapagliflozin initiation in acute decompensated heart failure patients with reduced left ventricular ejection fraction
by: Anastasiya E. Poskakalova, et al.
Published: (2023) -
Newer treatments for decompensated heart failure: focus on levosimendan
by: Ferenc Follath
Published: (2009) -
Acute decompensated heart failure. What has changed in the clinical guidelines in 2021?
by: Igor V. Zhirov, et al.
Published: (2022)